An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneum cancer	Recruiting	Phase 2	2026-07-13		NCT05887609

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340
University of Colorado, Denver	475

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Lennar	Irvine	United States	2
Northwestern Memorial Hospital	Chicago	United States	129
University Of Colorado Hospital	Aurora	United States	106
University of Pennsylvania Health System, Perelman Center for Advanced Medicine	Philadelphia	United States	3
University of Wisconsin - Carbone Cancer Center - University Hospital	Madison	United States	1
UPMC Magee-Women's Hospital	Pittsburgh	United States	1